Arctic Bioscience AS, a biotechnology company, engages in developing, manufacturing, and marketing pharmaceutical and nutraceutical ingredients based on natural and cultured marine membrane lipids. It is developing the investigational medicinal product, HRO350 for treatment of mild-to-moderate psoriasis. The company also offers herring caviar oil and protein nutraceuticals. It sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.
Stock data | 2024 | Change |
---|---|---|
Price | $0.17228050800662617 | N/A |
Market Cap | $4.37M | N/A |
Shares Outstanding | 25.37M | N/A |
Employees | 17.00 | N/A |